Weight Loss Drug Zepbound Officially in a Shortage | FDA Confirms

7 months ago
57

2024/04/09 Eli Lilly’s popular weight loss drug Zepbound has joined its competitor, Novo Nordisk’s Wegovy, in officially being hit by a shortage after the Food and Drug Administration confirmed that two doses of the drug, along with some doses of the company’s diabetes medication Mounjaro, are in limited supply.

Loading comments...